Sinovac Biotech established a new biotech company in Shenzhen
April 27, 2025
Source: drugdu
77
Recently, Shenzhen Baotekang Biotechnology Co., Ltd. was established, with Zhao Yanqing as the legal representative and a registered capital of 1 million yuan. Its business scope includes: manufacturing of bio-based materials; sales of bio-based materials; sales of sanitary products and disposable medical products; retail of cosmetics, etc. According to the equity penetration of Qichacha, the company is wholly owned by Sinovac Biotech.
https://finance.eastmoney.com/a/202504243387405326.html
By editor
Copyright©2025 Ddu. All rights reserved.
Read more on
- Integrating pharmacogenomics into everyday clinical practice can transform patient care May 28, 2025
- MRI scans reveal why young women face higher risk for eating disorders May 28, 2025
- Guangdong Province launches quantity based procurement, including 170 drugs and 248 product specifications | early reference materials for pharmaceuticals May 28, 2025
- 21 Health News Daily | Yuheng Pharmaceutical and Xinghe Pharmaceutical signed a promotion agreement; Shareholders of Chengdu Pioneer and Aojing Medical reduce their holdings May 28, 2025
- Kexing Biotech’s wholly-owned subsidiary is approved to conduct clinical trials of GB18 injection May 28, 2025
your submission has already been received.
OK
Subscribe
Please enter a valid Email address！
Submit
The most relevant industry news & insight will be sent to you every two weeks.
